Clinical Trials Directory

Trials / Completed

CompletedNCT00428363

Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
52 (planned)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Purpose: To compare the posterior capsule opacification (PCO) inhibiting effect of the sharp posterior optic edge design of the Clariflex silicone intraocular lens (IOL) with that of the double-round edge design of the SI40 (Phacoflex) silicone IOL over a period of 3 years. Setting: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. Methods: Fifty-two patients with bilateral age-related cataract (104 eyes) were included in this randomized, prospective, bilateral, patient- and examiner-masked clinical trial with intra-individual comparison. Each study patient had cataract surgery in both eyes and received an SI40 IOL (anterior and posterior round optic edges) in one eye and a Clariflex IOL with OptiEdge (round anterior and sharp posterior optic edge) in the other eye. Follow-up examinations were at one week, one month, six months, one, two, and three years. Digital retroillumination images were taken of each eye. The amount of PCO was assessed subjectively at the slit-lamp and objectively using automated image analysis software (AQUA) one, two, and three years after surgery.

Conditions

Interventions

TypeNameDescription
DEVICECataract surgery with implantation of an intraocular lens

Timeline

Start date
2001-06-01
Completion
2006-03-01
First posted
2007-01-30
Last updated
2007-01-30

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00428363. Inclusion in this directory is not an endorsement.

Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification (NCT00428363) · Clinical Trials Directory